TY - JOUR
T1 - Valvular heart disease
T2 - Diagnosis and management
AU - Maganti, Kameswari
AU - Rigolin, Vera H.
AU - Sarano, Maurice Enriquez
AU - Bonow, Robert O.
PY - 2010/5
Y1 - 2010/5
N2 - Valvular heart disease (VHD) encompasses a number of common cardiovascular conditions that account for 10% to 20% of all cardiac surgical procedures in the United States. A better understanding of the natural history coupled with the major advances in diagnostic imaging, interventional cardiology, and surgical approaches have resulted in accurate diagnosis and appropriate selection of patients for therapeutic interventions. A thorough understanding of the various valvular disorders is important to aid in the management of patients with VHD. Appropriate work-up for patients with VHD includes a thorough history for evaluation of causes and symptoms, accurate assessment of the severity of the valvular abnormality by examination, appropriate diagnostic testing, and accurate quantification of the severity of valve dysfunction and therapeutic interventions, if necessary. It is also important to understand the role of the therapeutic interventions vs the natural history of the disease in the assessment of outcomes. Prophylaxis for infective endocarditis is no longer recommended unless the patient has a history of endocarditis or a prosthetic valve.
AB - Valvular heart disease (VHD) encompasses a number of common cardiovascular conditions that account for 10% to 20% of all cardiac surgical procedures in the United States. A better understanding of the natural history coupled with the major advances in diagnostic imaging, interventional cardiology, and surgical approaches have resulted in accurate diagnosis and appropriate selection of patients for therapeutic interventions. A thorough understanding of the various valvular disorders is important to aid in the management of patients with VHD. Appropriate work-up for patients with VHD includes a thorough history for evaluation of causes and symptoms, accurate assessment of the severity of the valvular abnormality by examination, appropriate diagnostic testing, and accurate quantification of the severity of valve dysfunction and therapeutic interventions, if necessary. It is also important to understand the role of the therapeutic interventions vs the natural history of the disease in the assessment of outcomes. Prophylaxis for infective endocarditis is no longer recommended unless the patient has a history of endocarditis or a prosthetic valve.
UR - http://www.scopus.com/inward/record.url?scp=77951820306&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77951820306&partnerID=8YFLogxK
U2 - 10.4065/mcp.2009.0706
DO - 10.4065/mcp.2009.0706
M3 - Article
AN - SCOPUS:77951820306
SN - 0025-6196
VL - 85
SP - 483
EP - 500
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 5
ER -